Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy

[1]  B. Butler,et al.  National Practice Patterns and Outcomes for T4b Urothelial Cancer of the Bladder , 2017, Clinical genitourinary cancer.

[2]  B. Calhoun,et al.  Predictive factors on outcomes in metaplastic breast cancer , 2017, Breast Cancer Research and Treatment.

[3]  D. Gaffney,et al.  Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. B. Butler,et al.  Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma , 2017, Journal of Neuro-Oncology.

[5]  S. Adams.  Dramatic response of metaplastic breast cancer to chemo-immunotherapy , 2017, npj Breast Cancer.

[6]  J. Edenfield,et al.  Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution , 2017, Clinical breast cancer.

[7]  O. Elemento,et al.  Role of RPL39 in Metaplastic Breast Cancer , 2017, Journal of the National Cancer Institute.

[8]  E. Kotteas,et al.  Management and Outcomes in Metaplastic Breast Cancer. , 2016, Clinical breast cancer.

[9]  J. Lee,et al.  Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07). , 2015, Clinical breast cancer.

[10]  S. Moulder,et al.  Metaplastic Breast Cancer: Clinical Overview and Molecular Aberrations for Potential Targeted Therapy , 2015, Current Oncology Reports.

[11]  R. Peto,et al.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[12]  EBCTCG (Early Breast Cancer Trialists' Collaborati.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[13]  T. Koehler,et al.  Hormone Receptor Status Does Not Affect Prognosis in Metaplastic Breast Cancer: A Population-Based Analysis with Comparison to Infiltrating Ductal and Lobular Carcinomas , 2014, Annals of Surgical Oncology.

[14]  B. Haffty.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials: EBCTCG (Early Breast Cancer Trialists' Collaborative Group) () Lancet 383:2127-2135, 2014§ , 2014 .

[15]  R. Nelson,et al.  Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis , 2014, Annals of Surgical Oncology.

[16]  E. Hsueh,et al.  Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies , 2013, Experimental Hematology & Oncology.

[17]  J. Lee,et al.  The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients , 2011, Breast Cancer Research and Treatment.

[18]  S. Martinez,et al.  Metaplastic Breast Cancer: To Radiate or Not to Radiate? , 2010, Annals of Surgical Oncology.

[19]  Byung-Ho Nam,et al.  Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer , 2010, Breast Cancer Research and Treatment.

[20]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[21]  K. Bland,et al.  Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data Base , 2006, Annals of Surgical Oncology.

[22]  L. Lai,et al.  Metaplastic Breast Cancer: Clinical Features and Outcomes , 2005, The American surgeon.

[23]  D. Wazer,et al.  Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. , 1998, International journal of radiation oncology, biology, physics.